Tian, X., Yang, Q., & Wu, J. (2024). Effect of Apatinib Mesylate on Clinical Remission Rate and Adverse Reactions in Patients with Advanced Primary Hepatocellular Carcinoma. International Journal of Biology and Life Sciences, 5(1), 13-16. https://doi.org/10.54097/t3s4wp88